skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

The warfarin–cranberry juice interaction revisited: A systematic in vitro–in vivo evaluation

Original Research

(1688) Views  (833) Full article downloads

Authors: Ngoc Ngo, Scott J Brantley, Daniel R Carrizosa, et al

Published Date July 2010 Volume 2010:2 Pages 83 - 91
DOI: http://dx.doi.org/10.2147/JEP.S11719

Ngoc Ngo1, Scott J Brantley1, Daniel R Carrizosa2, Angela DM Kashuba1, E Claire Dees2, David J Kroll3, Nicholas H Oberlies4, Mary F Paine1

1UNC Eshelman School of Pharmacy and 2Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; 3Biomanufacturing Research Institute and Technology Enterprise and the Department of Pharmaceutical Sciences, North Carolina Central University, Durham, NC, USA; 4Department of Chemistry and Biochemistry, The University of North Carolina at Greensboro, Greensboro, NC, USA

Background: Cranberry products have been implicated in several case reports to enhance the anticoagulant effect of warfarin. The mechanism could involve inhibition of the hepatic CYP2C9-mediated metabolic clearance of warfarin by components in cranberry. Because dietary/natural substances vary substantially in bioactive ingredient composition, multiple cranberry products were evaluated in vitro before testing this hypothesis in vivo.

Methods: The inhibitory effects of five types of cranberry juices were compared with those of water on CYP2C9 activity (S-warfarin 7-hydroxylation) in human liver microsomes (HLM). The most potent juice was compared with water on S/R-warfarin pharmacokinetics in 16 healthy participants given a single dose of warfarin 10 mg.

Results: Only one juice inhibited S-warfarin 7-hydroxylation in HLM in a concentration-dependent manner (P < 0.05), from 20% to >95% at 0.05% to 0.5% juice (v/v), respectively. However, this juice had no effect on the geometric mean AUC00-oo and terminal half-life of S/R-warfarin in human subjects.

Conclusions: A cranberry juice that inhibited warfarin metabolism in HLM had no effect on warfarin clearance in healthy participants. The lack of an in vitro–in vivo concordance likely reflects the fact that the site of warfarin metabolism (liver) is remote from the site of exposure to the inhibitory components in the cranberry juice (intestine).

Keywords: warfarin, cranberry, interaction, CYP2C9, metabolism, inhibition






Readers of this article also read:

Potential antidiabetic and antioxidant activities of Morus indica and Asystasia gangetica in alloxan-induced diabetes mellitus
Effect of amlodipine, a calcium channel antagonist, on gonadal steroid of male wistar albino rats
The influence of dexamethasone and the role of some antioxidant vitamins in the pathogenesis of experimental bronchial asthma
Current and emerging therapies for the treatment of osteoporosis
Investigational new drugs in the treatment of inflammatory bowel disease: a review
Effects of single-dose morning and evening administration of pravastatin on antioxidant markers in cholesterol-fed rabbits
Changes in neutrophil activity following cardiovascular surgery
Hibiscus sabdariffa L., roselle calyx, from ethnobotany to pharmacology
Antiarthritic effect of aqueous and ethanolic leaf extracts of Pistia stratiotes in adjuvant-induced arthritis in Sprague-Dawley rats
A study of longitudinal data examining concomitance of pain and cognition in an elderly long-term care population
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University